AM-2201 is a recreational design drug that can act as an effective but non-selective full agonist of cannabinoid receptors. It is a drug that acts as a potent but non-selective agonist of the cannabinoid CB1 or CB2 receptor. Buy AM-2201.
Full Chemical Name: AM-2201
Systematic IUPAC Name 1-[(5-fluoropentyl)-1H- indol-3-yl]-(naphthalen-1-yl) methanone
CAS Number 335161-24-5
ChemSpider Number 24751884
Molecular Formula C44H22FNO
Molecular Mass 359.435 g/mol
What is AM-2201?
AM-2201 is a research chemical of the Cannabinoid family. At the Cannabinoid receptor, AM-2201 is a non selective full agonist. Discovered by Alexandros Makriyannis, AM-2201 is part of the AM Series of cannabinoid receptor ligand. AM-2201 is active at extremely low quantities, as low as 0.02g.
What is AM-2201 used for?
AM-2201 can be used to further research the in vitro (outside living organism) efficacy it has upon the cannabinoid receptors. Due to its non-selectivity, AM-2201 is useful for broad ligand binding assays into the affinity (potency) and duration of action upon receptors. Affinities are: Ki of 1.0nM at CB1 and 2.6nM at CB2. AM-2201 can be combusted using heat to produce a vapour. This vapour is useful as it contains AM-2201 with a high surface area, enabling efficient contact when applied to a membrane containing cannabinoid receptors CB1 and CB2.